Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Fierce Pharma Asia—Takeda Pharmaceutical’s $1.3 billion restructuring. GLP-1 sluice gate in India. Gilead acquires new Chinese company for $2.2 billion
By healthadmin
Takeda Pharmaceutical is embarking on a restructuring plan with the goal of saving about $1.3…
Family-owned Recordati, which is celebrating its 100th anniversary, is considering an acquisition offer from CVC…
With significant expansion works taking shape on both sides of the pond, specialist CDMO Hovione…
As questions swirl over ATTR competition, Alnylam plots Amvuttra’s path to market leadership
By healthadmin
Aruniram has big ambitions for Amvutra. However, despite the launch of explosive transthyretin amyloid cardiomyopathy…
Dr. Robert Malone, a physician and biochemist who became the prominent public face of the…
Corcept’s flagship drug recovers from FDA snub with different approval from Rifiorri for ovarian cancer
By healthadmin
Following a new U.S. green light for some ovarian cancer patients, Corcept Therapeutics has redeemed…
Ionis Pharmaceuticals is slashing the price of its expected blockbuster drug, Tringolza (olesarsen), in preparation…
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for inherited lysosomal storage diseases, breaking…
In the past seven months, Boehringer Ingelheim has won approval and label extensions in the…
South Korea’s Arteogen ensnared another big pharma partner, Biogen, after luring GSK, which topped this…